We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > About Us > Amy Reichelt, PhD

Amy Reichelt, PhD

Chief Innovation Officer, PurMinds Neuropharma

Dr. Reichelt is a recognized leader in neuroscience and neuropharmacology, specializing in psychedelic clinical development, neurodegeneration, and nutritional neurobiology, with 15 years of expertise in translational medicine spanning from molecules to mind. Dr. Reichelt received her PhD from Cardiff University, and has held academic appointments at globally renowned universities in Australia, Canada and UK. Dr. Reichelt has authored over 50 articles in top-tier scientific journals, spoken on international stages including Microdose Wonderland and TEDxSydney, and appeared as a scientific expert in TV productions including ABC’s The Science of Drugs.

The Neuroscience of Psychedelics – Harnessing Neuroplasticity for New Therapeutics

Join Dr. Reichelt on December 14 for this exclusive webinar which will explore the neurobiology of psychedelics, emphasizing their role in promoting neuroplasticity.